Cargando…

Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer

OBJECTIVE: The purpose of this study was to employ dual tracers 16α-[18F]fluoro-17β-estradiol ((18)F-FES) and [18F]fluorodeoxyglucose ((18)F-FDG) as imaging biomarkers in predicting progression-free survival (PFS) in ER-positive metastatic breast cancer (MBC) patients receiving fulvestrant therapy....

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Cheng, Xu, Xiaoping, Yuan, Huiyu, Zhang, Yongping, Zhang, Yingjian, Song, Shaoli, Yang, Zhongyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673439/ https://www.ncbi.nlm.nih.gov/pubmed/33251143 http://dx.doi.org/10.3389/fonc.2020.580277

Ejemplares similares

Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study
por: Zhao, Yannan, et al.
Publicado: (2018)

A preliminary study of (18)F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel
por: Gong, Chengcheng, et al.
Publicado: (2017)

Automated radiosynthesis of two (18)F-labeled tracers containing 3-fluoro-2-hydroxypropyl moiety, [(18)F]FMISO and [(18)F]PM-PBB3, via [(18)F]epifluorohydrin
por: Ohkubo, Takayuki, et al.
Publicado: (2021)

(18)F-Fluorodeoxyglucose Uptake and Tumor Hypoxia: Revisit (18)F-Fluorodeoxyglucose in Oncology Application
por: Li, Xiao-Feng, et al.
Publicado: (2014)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Comparison of (18)F-FES, (18)F-FDG, and (18)F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer
por: He, SiMin, et al.
Publicado: (2016)

Can Positron Emission Tomography/Computed Tomography with the Dual Tracers Fluorine-18 Fluoroestradiol and Fluorodeoxyglucose Predict Neoadjuvant Chemotherapy Response of Breast Cancer? ----A Pilot Study
por: Yang, Zhongyi, et al.
Publicado: (2013)

Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal (18)F-FES PET/CT
por: He, SiMin, et al.
Publicado: (2019)

The hot embolus of (18)F-fluorodeoxyglucose
por: Hussain, Riffat Parveen, et al.
Publicado: (2020)

Adding Maximum Standard Uptake Value of Primary Lesion and Lymph Nodes in (18)F-Fluorodeoxyglucose PET Helps Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma
por: Shi, Qi, et al.
Publicado: (2014)

Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET
por: Yoshida, Yoshio, et al.
Publicado: (2009)

7-[(18)F]Fluoro-8-azaisatoic Anhydrides: Versatile Prosthetic Groups for the Preparation of PET Tracers
por: Gröner, Benedikt, et al.
Publicado: (2023)

18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer
por: Cheng, Jingyi, et al.
Publicado: (2015)

Comparison of New Tau PET-Tracer Candidates With [(18)F]T808 and [(18)F]T807
por: Declercq, Lieven, et al.
Publicado: (2016)

(18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy
por: Hodolic, Marina, et al.
Publicado: (2016)

Evaluation of tumour heterogeneity by (18)F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment
por: Liu, Cheng, et al.
Publicado: (2022)

Preparation of N(In)-Methyl-6-[(18)F]fluoro- and 5-Hydroxy-7-[(18)F]fluorotryptophans as Candidate PET-Tracers for Pathway-Specific Visualization of Tryptophan Metabolism
por: Kolks, Niklas, et al.
Publicado: (2023)

PET Imaging of Hepatocellular Carcinomas: (18)F-Fluoropropionic Acid as a Complementary Radiotracer for (18)F-Fluorodeoxyglucose
por: Zhao, Jing, et al.
Publicado: (2019)

Radiosynthesis and validation of (±)-[(18)F]-3-fluoro-2-hydroxypropionate ([(18)F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors
por: Van Hée, Vincent F., et al.
Publicado: (2017)

Radiosynthesis of the norepinephrine transporter tracer [(18)F]NS12137 via copper‐mediated (18) F‐labelling
por: Lahdenpohja, Salla, et al.
Publicado: (2019)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Herniated Urinary Bladder Detected on (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Scan Imitating as (18)F-Fluorodeoxyglucose Avid Lesion
por: Gupta, Nitin, et al.
Publicado: (2020)

(18)F-labeled tracers targeting fibroblast activation protein
por: Lindner, Thomas, et al.
Publicado: (2021)

Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
por: Vogel, Jonas, et al.
Publicado: (2023)

The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011)

F18 fluorodeoxyglucose uptake in progressive transformation of germinal centres
por: Rehani, B, et al.
Publicado: (2008)

Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009)

Mechanisms underlying (18)F-fluorodeoxyglucose accumulation in colorectal cancer
por: Kawada, Kenji, et al.
Publicado: (2016)

Determinants of physiological uptake of (18)F-fluorodeoxyglucose in palatine tonsils
por: Birkin, Emily, et al.
Publicado: (2018)

Takayasu arteritis detected by PET/MRI with (18)F-fluorodeoxyglucose
por: Takeishi, Yasuchika, et al.
Publicado: (2018)

Physiologic Testicular Uptake of 18-F Fluorodeoxyglucose in the Indian Population
por: Parida, Girish Kumar, et al.
Publicado: (2021)

Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)

Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020)

Head-to-head comparison of tau positron emission tomography tracers [(18)F]flortaucipir and [(18)F]RO948
por: Smith, Ruben, et al.
Publicado: (2019)

Ascorbic acid analogue 6-Deoxy-6-[(18)F] fluoro-L-ascorbic acid as a tracer for identifying human colorectal cancer with SVCT2 overexpression
por: He, Peng, et al.
Publicado: (2021)

The Diagnostic Value of Fluoro-18 Fluorodeoxyglucose (F-18 FDG) PET/CT in Fever or Inflammation of Unknown Origin: A Retrospective Study at a Rheumatology Clinic
por: Öğüt, Tahir Saygın, et al.
Publicado: (2022)

Mismatched intratumoral distribution of [(18)F] fluorodeoxyglucose and 3′-deoxy-3′-[(18)F] fluorothymidine in patients with lung cancer
por: Wang, Xiangcheng, et al.
Publicado: (2017)

Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3′-deoxy-3′-[18F] fluorothymidine in patients with lung cancer
por: Wang, Xiangcheng, et al.
Publicado: (2018)

Analysis of (18)F-Fluorodeoxyglucose and (18)F-Fluoride Positron Emission Tomography in Korean Stroke Patients with Carotid Atherosclerosis
por: Kim, Jeong-Min, et al.
Publicado: (2019)

Tracer‐specific reference tissues selection improves detection of (18)F‐FDG, (18)F‐florbetapir, and (18)F‐flortaucipir PET SUVR changes in Alzheimer's disease
por: Li, Yanxiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g19vjf8kls7po07jdl5anm1hq0